Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-17-033512)

Filing Details

Accession Number:: 0001104659-17-033512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-17 17:43:02
Reporting Period:: 2017-05-15

Filing Date:: 2017-05-17
Accepted Time:: 2017-05-17 17:43:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Novelion Therapeutics Inc.	NVLN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376960	Jason Aryeh	C/O Novelion Therapeutics Inc. 887 Great Northern Way, Suite 250 Vancouver A1 V5T 4T5		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2017-05-15	361	$8.95	242,433	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	127,491	Indirect	By JALAA Equities, L.P.
Common Shares	6,256	Indirect	By JLV Investments, LP
Common Shares	16,553	Indirect	By JLD Investments, L.P.

Footnotes

Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016.
The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest.